INS and hydrops fetalis: After a 26-week experiment, low-dose THE treatment significantly reduced elevated plasma glucose (by 7.85%) and insulin (by 23.67%) levels, but did not significantly affect body weight, liver weight, abdominal adipose weight, or plasma T-CHO, TG, and LDL-C levels compared to HF group mice.